Drug Profile
Staphylococcal vaccine - SIGA
Latest Information Update: 23 Sep 2014
Price :
$50
*
At a glance
- Originator Nonindustrial source; SIGA Technologies
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Staphylococcal infections
Most Recent Events
- 26 Apr 2005 Discontinued - Preclinical for Staphylococcal infections in USA (unspecified route)
- 17 Nov 1998 New profile
- 17 Nov 1998 Preclinical development for Staphylococcal infections in USA (Unknown route)